Needham Reiterates Buy on ISIS (ISIS) Following Narrow FDA Vote for Approval of Kynamro
Go back to Needham Reiterates Buy on ISIS (ISIS) Following Narrow FDA Vote for Approval of Kynamro| Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) | Delayed: 57.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.56 | 52 Week High | $77.80 | |||
| Open | $3.73 | 52 Week Low | $37.38 | |||
| Day High | $57.56 | P/E | N/A | |||
| Day Low | $57.56 | EPS | $-0.35 | |||
| Volume | 15 | |||||
